Halozyme Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,241,829

Value ($000)

83,575

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	83,575	0.0%	1,241,829	12/31/2025
2025 Q3	11/10/2025	92,509	0.0%	1,261,375	9/30/2025
2025 Q2	8/12/2025	69,854	0.0%	1,342,831	6/30/2025
2025 Q1	9/15/2025	111,594	0.0%	1,748,851	3/31/2025
2024 Q4	2/6/2025	85,254	0.0%	1,783,177	12/31/2024
2024 Q3	11/12/2024	101,509	0.0%	1,773,397	9/30/2024
2024 Q2	8/12/2024	93,596	0.0%	1,787,548	6/30/2024
2024 Q1	5/9/2024	67,833	0.0%	1,667,479	3/31/2024
2023 Q4	2/6/2024	64,167	0.0%	1,736,122	12/31/2023
2023 Q3	11/8/2023	64,877	0.0%	1,698,359	9/30/2023
2023 Q2	8/10/2023	60,686	0.0%	1,682,457	6/30/2023
2023 Q1	5/12/2023	64,387	0.0%	1,685,975	3/31/2023
2022 Q4	2/13/2023	91,780	0.0%	1,613,006	12/31/2022
2022 Q3	11/14/2022	63,682	0.0%	1,610,579	9/30/2022
2022 Q2	8/15/2022	55,349	0.0%	1,257,917	6/30/2022
2022 Q1	5/13/2022	52,849	0.0%	1,325,197	3/31/2022
2021 Q4	2/11/2022	52,057	0.0%	1,294,615	12/31/2021
2021 Q3	11/16/2021	53,473	0.0%	1,314,466	9/30/2021
2021 Q2	8/16/2021	55,820	0.0%	1,229,243	6/30/2021
2021 Q1	5/17/2021	47,705	0.0%	1,144,269	3/31/2021
2020 Q4	2/16/2021	40,409	0.0%	946,113	12/31/2020
2020 Q3	11/13/2020	24,870	0.0%	946,317	9/30/2020
2020 Q2	8/20/2020	24,000	0.0%	895,161	6/30/2020
2020 Q1	5/15/2020	15,267	0.0%	848,614	3/31/2020
2019 Q4	2/7/2020	15,716	0.0%	886,362	12/31/2019
2014 Q2	7/30/2014	2,769	0.0%	280,183	6/30/2014
2014 Q1	4/29/2014	3,443	0.0%	271,047	3/31/2014
2013 Q4	2/14/2014	3,706	0.0%	247,174	12/31/2013